Zealthy Review: Credentialing, Compounding, Oversight

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This review is published through the PlexusDx Education Hub, our library of evidence-based guidance on GLP-1 programs, weight management, and the genetics behind metabolic care. Browse all Peptides & GLP-1 education

Independent editorial review. PlexusDx has no commercial relationship with Zealthy or its parent company, and this page carries no affiliate links or paid placement.

"Is Zealthy legit?" is really several questions bundled together: are the clinicians licensed, is the pharmacy pathway legitimate, is there real oversight, and is the pricing honest? Rather than a thumbs-up or thumbs-down, this review works through those credentialing signals one at a time, in fair-balance fashion, as of April 2026.

Evaluating legitimacy, not hype

Zealthy operates as subscription telehealth. Judging legitimacy in this model means looking past marketing at structural markers: who evaluates the patient, where prescriptions are filled, and how care continues afterward. The company publishes its current program and pricing on its own site — see Zealthy's official website — which is the primary source to verify any specific claim.

Provider licensing and credentialing

A legitimate telehealth program routes each patient through a licensed clinician who reviews an intake covering weight, medical history, and current medications before any prescription is written. Provider type can vary — physician, nurse practitioner, or physician assistant — and prospective patients can confirm licensure through state boards. Credentialing transparency is one of the clearest signals separating a legitimate operator from a marketing front.

The 503A compounding pathway explained

When a program dispenses compounded semaglutide or tirzepatide, it should do so through a 503A compounding pharmacy — a state-licensed facility that prepares medications for an individual patient's prescription. This is a legitimate regulatory pathway distinct from FDA-approved brand manufacturing. Understanding whether a program uses retail brand fulfillment or 503A compounding clarifies exactly what a patient is receiving.

Clinical oversight and follow-up

Oversight does not end at the prescription. In a credible model, ongoing telehealth follow-up supports dose titration and side-effect management over time. The presence of structured follow-up — rather than a one-time script — is a meaningful marker of clinical seriousness and a fair thing to ask about before committing.

Pricing transparency and reputation posture

Honest pricing is part of legitimacy. Zealthy's fees appear on its own website and shift over time; typical monthly totals across the telehealth GLP-1 market as of April 2026 fall between roughly $200 and $700+, with wide variance by product, tier, and dispensing pathway. A program that shows costs plainly before purchase earns more trust than one that hides them behind an intake wall. Always confirm current numbers at the source.

The genetic layer telehealth reviews skip

Even a well-credentialed program prescribes without reading your underlying biology. Variants in FTO (appetite and adiposity set-point), GLP1R (the receptor every GLP-1 compound targets), MC4R (energy balance), and TCF7L2 (glucose homeostasis and GLP-1 secretion) describe the metabolic terrain a clinician prescribes into. They are pathway-level and do not predict response to any compound — but they are context a telehealth intake alone does not capture.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, alongside the Precision Peptide Genetic Test, which analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, MC4R, and TCF7L2. The genetic test is priced transparently at $298, reflecting the same up-front posture a credible telehealth review should reward.

Not affiliated: PlexusDx has no ownership, partnership, or commercial tie to Zealthy; this review is editorial only.

Related reading on PlexusDx: What Is GLP-1, GLP-1 Receptor Agonist, and GLP-1 Drugs.

Editorial note: this review is educational and not a buying recommendation. PlexusDx is not affiliated with Zealthy. The Precision Peptide Genetic Test analyzes how genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified provider before beginning any protocol.

Compare the approaches: see the Weight Management Protocols, or start with the Precision Peptide Genetic Test.

Frequently Asked Questions

How can I verify that a Zealthy clinician is licensed?

Legitimate telehealth uses clinicians licensed in your state, and you can confirm a provider's license through the relevant state medical, nursing, or pharmacy board. Zealthy publishes program details on its own site; credentialing and licensure should be verifiable there or through public board records before any purchase.

What is a 503A compounding pharmacy?

A 503A pharmacy is a state-licensed facility that prepares a medication for an individual patient's prescription. When a telehealth program dispenses compounded semaglutide or tirzepatide, this is the legitimate pathway involved. It differs from FDA-approved brand manufacturing, so knowing which pathway a program uses clarifies what you receive.

Does a lower price mean a program isn't legitimate?

Not necessarily. Price reflects product, subscription tier, and whether a program dispenses brand or compounded medication. Legitimacy is better judged by clinician licensing, pharmacy pathway, oversight, and pricing transparency than by cost alone. Verify these markers on the brand's own site rather than inferring from the headline number.

Does the Precision Peptide Genetic Test evaluate Zealthy?

No. It does not assess any telehealth program or predict response to a compound. It reads pathway-level variants in FTO and MC4R, and TCF7L2 that describe your baseline GLP-1 biology — upstream context that applies regardless of which program prescribes a medication.

Continue at the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.